Abstract. Hepatic stellate cell (HSC) activation is the critical event of liver fibrosis. Abnormality of miR-16 expression induces their activation. However, the action model of miR-16 remains to be elucidated because of its multiple-targeted manner. Here, we report that miR-16 restoration exerted a wide-range impact on transcriptome (2,082 differentially expressed transcripts) of activated HSCs. Integrative analysis of both targetome (1,195 targets) and transcriptome uncovered the miR-16 regulatory network based upon bio-molecular interaction databases (BIND, BioGrid, Tranfac, and KEGG), cross database searching with iterative algorithm, Dijkstra's algorithm with greedy method, etc. Eight targets in the targetome (Map2k1, Bmpr1b, Nf1, Pik3r3, Ppp2r1a, Prkca, Smad2, and Sos2) served as key regulatory network nodes that mediate miR-16 action. A set of TFs (Sp1, Jun, Crebl, Arnt, Fos, and Nf1) was recognized to be the functional layer of key nodes, which mapped the signal of miR-16 to transcriptome. In result, the comprehensive action of miR-16 abrogated transcriptomic characteristics that determined the phenotypes of activated HSCs, including active proliferation, ECM deposition, and apoptosis resistance. Therefore, a multi-layer regulatory network based upon the integration of targetome and transcriptome may underlie the global action of miR-16, which suggesting it plays an inhibitory role in HSC activation.
Introduction
Hepatic stellate cells (HSCs) are mesenchymal cells with vitamin A-containing lipid droplets in the liver. Upon stimulation, they experience phenotypic transdifferentiation, also known as activation, toward myofibroblast. Activated HSCs serve as effector cells in the initiation as well as the progression of liver fibrogenesis [1] . Thus, activated HSCs qualify them to be a therapeutic target of liver fibrosis/cirrhosis.
Presently, miR-16 is proved to be a critical regulator in HSCs. miR-16 administration significantly reduces Bcl-2 expression, which is responsible for the apoptosis resistance of activated HSCs. This elevates apoptosis rate by activation of caspases [1] . Moreover, restoring intracellular miR-16 inhibits the translational level of cyclinD1 (CCND1), a pivotal member of the cell cycle. Thus, activated HSC proliferation is restricted as a result of cell-cycle arrest [1] . However, despite its potential role in diminishing activated HSCs, miR-16 is still not incorporated into fibrosis prevention because of its multiple targets and, subsequently, the indefiniteness of its global action.
Fortunately, recent studies uncovered that a single miRNA is able to comprehensively shift the cellular transcriptome towards another status in which it is specially expressed [2] . Furthermore, signal transduction from the miRNA-specific targetome to the transcriptome has been suggested to underlie the global action of miRNA. We, therefore, obtained the targetome of miR-16 by the miRanda and TargetScan databases. miR-16's effect on the transcriptome of activated HSCs was investigated by miR-16 restoration and array hybridization. Then, a multiple-layer regulatory network, which mediates the signal transduction from the targetome to the transcriptome, was constructed based upon biomolecular interaction databases, cross database searching with iterative algorithm, Dijkstra's algorithm with greedy method, etc. Consequently, the global role of miR-16 in HSC activation was highlighted by integrating the targetome, transcriptome, and miR-16 regulatory network.
Materials and methods

miR-16 treatment of HSCs
Activated HSCs were isolated from adult male Sprague-Dawley rats (Shanghai Laboratory Animal Center of the Chinese Academy of Sciences), that had carbon tetrachloride (CCl 4 )-induced liver fibrosis, by in situ perfusion and density-gradient centrifugation. HSCs purity was 90% when assessed by the significant expression of a-SMA and desmin, and negative expression of albumin (ALB), CD31, CD68, and cytokeratin-19 (CK-19) [1] . All procedures conformed to guidelines laid out by the World Medical Assembly (Declaration of Helsinki) and were approved by the Ethical Committee of Xinhua Hospital.
Recombinant Lentiviruses (pLV-miR-16 and pLV-GFP) were constructed by the co-transfection of miRNA expression vectors [either with precursor rno-miR-16 (pre-rno-miR-16, MI0000844) (pCDH-CMV-MCS-EF1-copGFP-miR-16) or without rno-miR-16 exogenous oligonucleotides (pCDH-CMV-MCS-EF1-copGFP)] and the Lentivirus Package plasmid mix (System Biosciences, Mountain View, CA, U.S.A.) in 293TN cells as previously described [1] . Exponentially growing activated HSCs were then divided into pLV-miR-16-treated and pLV-GFPtreated groups at random and then infected with pLV-miR-16 and pLV-GFP, respectively, at 1.0×10 the pLV-miR-16-treated group elevated approximately 2-fold. However, the miR-16 expression remained constant in the pLV-GFP-treated group.
Microarray hybridization for the miR-16-regulated transcriptome
The total RNA of the HSCs, derived from both the pLV-miR-16-treated group (n=3) and the pLV-GFP-treated group (n=3) 48 h after the lentivirus transfection, was extracted using the TRIzol reagent. After RNA purification and cRNA preparation, Affymetrix rat 230 2.0 arrays (Affymetrix, Santa Clara, U.S.A.) were hybridized with biotin-labeled RNA probes.
Random variance model (RVM) was employed to normalize the obtained data, and to filter the significantly up-regulated and down-regulated transcripts on the basis of P value of RVM t-test (<0.05) and false discovery rate (FDR) (<0.05) [3] . RT-QPCR for 6 randomly selected genes, Cav1, ICAM1, Mmp2, Ezr, Casp3 and Col1a1, confirmed the reliability of the array hybridization.
Targetome analysis of miR-16
Taking advantage of the widely accepted arithmetics covering Rattus Norvegicus, the miR-16 targets were obtained by the following databases: miRBase [4] and TargetScan [5] , respectively. These predicted targets of were pooled to construct the targetome of miR-16.
Bioinformatics modeling for the regulatory network of miR-16 in HSCs
To purse the signal transduction from miR-16 targets to miR-16-regulated transcripts, the miR-16 targetome was designed to be a set of upstream proteins. Downstream proteins of the miR-16 targets were then found by multiple-step, trans-database iterative search, including BIND [6] , BioGrid [7] and KEGG [8] , on the basis of protein-protein interactions. On the other side, we use Tranfac database [9] to enquire the transcription factors (TFs) up-stream to miR-16-regulated transcripts on the basis of TFmRNA binding. In result, a set of TFs were identified to be both the downstream protein of miR-16 targets and the up-stream protein of miR-16-regulated transcripts. Thus a regulatory network, connecting miR-16 targets, TFs, and miR-16-regulated transcripts, was generated.
Thereafter, we assigned the miR-16 targets and target-related TFs to be source vertex and target vertex, respectively. Dijkstra's algorithm with greedy method was performed to uncover the shortest path from source vertex to target vertex ( Figure 1 ). Depending on this optimization, the HSC-specific regulatory network of miR-16 with fewest node numbers was resultantly constructed. Moreover, we scored the Degree of each node, which reflected the sum of interactions between one node and the others, so as to evaluate the crucial ones in the network [10] .
According to the annotation of KEGG database, sub-networks relating to signal pathways were recognized and validated by normalized enrichment scoring (NES), Fisher's exact test and FDR analysis [11] . Those signal-pathway-based sub-networks with P-value less than 0.05 and FDR less than 0.05 were defined to be statistical significance.
Statistical analysis
The fold change of gene expression is expressed as mean ± standard deviation (SD). The statistical analysis was done with Student's t-test for comparing two groups. Differences with P < 0.05 were considered statistically significant. 
Results
Effect of miR-16 on the transcriptome of HSCs
In contrast to the pLV-GFP-treated HSCs, 1,162 transcripts (representing 3.74% of the total) were determined to be significantly up-regulated in the pLV-miR-16-treated HSCs at 48 hours. Meanwhile, 920 transcripts (2.96%) were statistically lowered under miR-16 control.
Most notably, miR-16-induced transcriptional characteristics strongly hindered HSC activation, as demonstrated by the following conclusions: (1) Genes that are critical for HSC proliferation, such as Cdc20, Pttg1, and Wee1, were expressed at decreased levels. Negative cell cycle regulators (e.g., Cdkn1a) were expressed at a level that was 6.63-fold above normal (Table 1) . (2) Differentially expressed genes that are specific for ECM synthesis, secretion and degradation detailed the remaining action of miR-16 on the transcriptome. In detail, important fibrosis-inducing cytokines [Tgfb2 and collagens (Col1a1, Col3a1, Col5a3, Col12a1)] exhibited significantly decreased expression, whereas the fibrolysis-dependent matrix metallopeptidases (Mmp2, Mmp12, etc.) had up-regulated transcription after the miR-16 treatment (Table 1) . (3) Another noticeable phenomenon involved the genes that dominate mitochondrial apoptosis. Transcription of those that mediate the mitochondria-based apoptosis (including Casp3, Casp9, Ddit3, Dffa, etc.) increased 1.75-, 4.85-, 4.45-, and 1.59-fold within pLVmiR-16-treated HSCs (Table 1) .
Prediction algorithm recognized the targetome of miR-16
By first evaluating the complementarity between the seed sequence of miRNA and the 3' untranslated region (3'UTR) of mRNA, 1,034 genes were predicted by the miRanda algorithm to be the miR-16 target. However, the TargetScan algorithm predicted a set of miR-16 targets that consisted of 182 genes. In result, a union set of 1,195 genes reflected the miR-16 targetome. This covered most of the experimentally proven target of miR-16, including cyclin D1 (CCND1), Bcl-2, and Wnt3a, etc.
Modeling of regulatory network identified the effect of miR-16 on HSC activation
Integrating the targetome, transcriptome, and bio-molecular interaction database outlined the regulatory network of miR-16 in activated HSCs (Figure 2) . A group of miR-16 targets (Map2k1, Bmpr1b, Nf1, Pik3r3, Ppp2r1a, Prkca, Smad2, and Sos2) was suggested to be the central targetome components. They mediated the effect of miR-16 through various kinds of protein-protein interactions, being activation, indirect action, phosphorylation, inhibition, compound action on substrate, binding/association, and expression enhancing. Next, a set of TFs, including Sp1, Jun, Crebl, Arnt, Fos, and Nf1, served as the bottom layer of key nodes that are essential for the regulatory network (Figure 2 ). Differentially expressed genes, i.e. Cdc20, Cdkn1a, Col1a1, Col3a1, Col5a3, Col12a1, Mmp2, Mmp12, Tgfb2, Casp3, Casp9, Ddit3, and Dffa, were under the TF set's control (Table 1) . A large majority of these genes determined the HSC phenotypes of proliferation, ECM metabolism and apoptosis.
Some sub-networks had been recognized on the basis of signal pathway, being TGFȕ/Smad, PI3K/Akt, MAPK/ERK, and GnRH. Members of signal pathways (i.e. Mapks, Hras, Nras, Smads, Gsk3b) and TFs (i.e. Fos, Jun) took the critical place of sub-networks because of their high-ranking score of Degree (Table 2 ).
Discussion
The unique pattern of miRNAs' function, which directly targets hundreds of genes, has been well described. Furthermore, target prediction is a powerful methodfor obtaining an overview of their targetome. According to the miRBase and TargetScan algorithms, the miR-16 targets were predicted to be 1, 034 and 182, respectively. However, some differences exist between the miRBase and TargetScan algorithms due to following reasons: inconsistency in target recognition, ranking of prediction efficacy, site conservation, etc. Therefore, to overcome the algorithm-based bias in target prediction, we pooled two sets of predicted targets to construct the miR-16 targetome. Apart from its targetome, transcriptome analysis represents another important method for shedding light on the global action of miR-16. Indeed, array hybridization revealed the transcriptome-scale regulation of miR-16 after its restoration in the activated HSCs, which included 2,082 differentially expressed transcripts. Surprisingly, several characteristics were associated with the miR-16-induced tran Table 2 Signal pathways serve as sub-networks of miR-16 regulatory network scriptome. Firstly, miR-16 facilitated the significant down-regulation of genes (i.e. Cdc20, Pttg1, and Wee1) that are necessary for cell cycle and proliferation, whereas the strong up-regulation of genes (i.e. Cdkn1a) antagonizes these processes [12] . Secondly, miR-16 ameliorated the expression of the profibrogenic enzyme (i.e. P4ha3), cytokines (i.e Tgfb2) and collagens (i.e. Col1a1, Col3a1, Col5a3, Col12a1) as well as promoted ECM enzymolysis by MMPs (i.e. Mmp2, Mmp1) transcription [13] . Thirdly, miR-16 management introduced the high-level mRNAs (i.e. Casp3, Casp9, Ddit3, and Dffa) that are specific to mitochondrial apoptosis [14] . Therefore, the comprehensive effect of miR-16 abrogates the characteristic transcriptiome that determines pivotal phenotypes of activated HSCs, primarily the active proliferation, ECM deposition, and apoptosis resistance. An action model of miR-16 was then established to integrate the targetome and transcriptome findings. It was focused on the signal flow from the miR-16 targets to the miR-16-regulated genes based upon protein-protein interaction and TF-mRNA binding, both of which were subjected to a crossdatabase iterative search of a major repository of protein and TF information. Thus, a complicated network consisting of numerous miR-16 targets, downstream proteins, and TFs was presented as the underlying foundation of the global action of miR-16. In order to highlight the crucial members, this regulatory network was optimized by exploring the single source shortest path. As a result, there were 55 nodes in the regulatory network, consisting of 8 (14.55%) miR-16 targets, 43 (76.36%) downstream proteins, and 6 (10.91%) TFs.
As defined by the signal flow in the regulatory network, the set of miR-16 targets was recognized to be the top layer of key nodes. They mediated the regulatory information of miR-16 through interacting with multiple down-steam proteins, which are usually signaling pathways members. In detail, the miR-16-induced inhibition of Sos2 suppressed the MAPK/ERK signaling pathway via the inactivation of Kras, Hras, Nras, and Rasgrp1 [15] . The expression loss of Map2k1, the other miR-16 target in the MAPK/ERK signaling pathway, also blocked the signal pathway via the inactivation of Mapk1 and Mapk3 as well as the dephosphorylation of Mapk1, Mapk3, Mapk8, Mapk9, and Mapk10 [16] . Nevertheless, the targeted effect of miR-16 on Bmpr1b repressed the TGFȕ/Smad signaling pathway by dephosphorylated Smad1, Smad5, and Smad9 [17] . The complementarity between miR-16 and Smad2 similarly impacted the TGFȕ/Smad signaling through inactivation of Smad4, Crebbp, Ep300, and Sp1 as well as less binding/association of Smad4 [18] . Another important target of miR-16, Pik3r3, was demonstrated to activate Rac1 and Rac2, whereas it affected Akt1, Akt2, Akt3, and Frap1 through phosphorylation, compound action on the substrate, and indirect regulation [19] . On the other hand, its absence prevented the signaling transduction of PI3K/Akt. In contrast, Ppp2r1a acted as the negative regulator of signal pathways, including GnRH, MAPK/ERK, etc., by inducing an inhibitory effect on various downstream proteins, such as Prkca, Prkcc, Prkcb1, Map2k1, Map2k2, and Mapk3 [20] .
The stepwise protein-protein interaction, ranging from 1 to 4 steps, led to alternations in the activity and/or expression of TFs (Sp1, Jun, Crebl, Arnt, Fos, Nf1), which thereby qualified them for the bottom layer of key nodes in the regulatory network. The signals of the MAPK/ERK and TGFȕ/Smad signaling pathways were mapped to the TF binding domains of Col1a1 (Sp1, Nf1), Col3a1 (Jun), Col5a3 (Sp1), Col12a1 (Sp1), Mmp2 (Jun, Fos), Cdc20 (Sp1)), Cdkn1a (Sp1, Fos), Pttg1 (Sp1), Wee1 (Sp1, Fos), Birc3 (Sp1), Casp3 (Sp1), Ddit3 (Jun), Dffa (Sp1), and Serpine1 (Fos). The signaling pathways of TGFȕ/Smad and PI3K/Akt also controlled the Casp9 expression level via Arnt. Furthermore, the PI3K/Akt signaling pathway modulated both Mmp12 and Tgfb2 via the TF of Crebl. Consequently, the set of TFs was found to be an executor of the miR-16 regulatory network that bridged the gap between the targetome and transcriptome.
In conclusion, miR-16 exerts a wide-range effect on both the targetome and transcriptome of activated HSCs. A regulatory network of key targets and TFs underlies the signal transduction from the targetome to the transcriptome. Ultimately, integrating the targetome, transcriptome, and regulatory network uncovers the transcriptomic characteristics of miR-16-treated HSCs, including cell cycle arrest, collagen degradation, and apoptosis susceptibility. This global effect suggests that miR-16 plays an inhibitory role against the activation of HSCs.
